Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,904 shares at $134.24 ($541K) on 2024-02-08, disclosed to the SEC on 2024-02-08.
Scheduled sale ($541k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.17 | 1,041 | $148K | 27.4% |
| 2 | $142.17 | 1,041 | $148K | 27.4% |
| 3 | $134.24 | 911 | $122K | 22.6% |
| 4 | $134.24 | 911 | $122K | 22.6% |
| Total | $138.47 avg | 3,904 | $541K | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |